Edition:
United Kingdom

Biohaven Pharmaceutical Holding Company Ltd (BHVN.N)

BHVN.N on New York Stock Exchange

48.64USD
4:47pm BST
Change (% chg)

$1.61 (+3.42%)
Prev Close
$47.03
Open
$47.50
Day's High
$49.55
Day's Low
$47.50
Volume
67,715
Avg. Vol
195,724
52-wk High
$67.86
52-wk Low
$29.17

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Declan Doogan

67 Independent Chairman of the Board

Vlad Coric

48 2015 Chief Executive Officer, Director

James Engelhart

55 2016 Chief Financial Officer, Treasurer

Kimberly Gentile

53 2014 Senior Vice President - Clinical Operations

Charles Conway

57 2017 Chief Scientific Officer